Screening Libraries

Compound Library Advantages

Cost-effective and competitive price to save your findings.
Potent, selective and cell-permeable in inhibiting or activating target molecules.
Diverse in chemical structure and route of administration (oral/i.m/i.v injection etc.).
Detailed files describing potency, selectivity and applications etc.
Supported by published data from top peer-reviewed journals.
Guaranteed high quality with NMR and HPLC validation.

Bioactive Screening Libraries are ready-to-use chemical libraries used for drug discovery, lab drug screening, drug target identification, and other pharmaceutical-related applications. They are available for high-throughput screening (HTS) and high-content screening (HCS).

• The libraries consist of over 2,500 small molecules with validated biological and pharmacological activities. The solubility, purity and stability of the compounds are also proved. Safety and effectiveness of the compounds has been demonstrated by literature, preclinical and clinical research, and many compounds are FDA-approved.

• The collections of unique small molecules, which include inhibitors, antagonists and agonists. These compounds focused on hundreds of targets that are part of more than 20 signaling pathways or research areas, which include DNA Damage/DNA Repair, Cell Cycle/Checkpoint, JAK/STAT Signaling Pathway, MAPK Signaling Pathway, GPCR/G protein, Angiogenesis, Immunology/Inflammation, Endocrinology and Hormones, Cancer Biology, Metabolism, Stem Cell, etc.

• We also provide customized bioactive screening libraries that allow you to choose the compounds, the sizes, the quantities, the format (powder or solution) and plate map you want in the library.

Product Name	Catalog Number	Contents
FDA-approved Drug Library	L1021-APE	2320 approved drugs and API from pharmacopoeia.
Clinical & FDA approved Drug Libary	L1052-APE	A collection of 2726 clinical & FDA approved drugs supplied as lyophilized powder or pre-dissolved DMSO solutions.
Bioactive Compound Library	L1022-APE	3317 bioactive compounds
Bioactive Compound Library Plus	L1022P-APE	5072 bioactive compounds
Anti-cancer Compound Library	L1023-APE	1164 anti-cancer compounds
Anti-cancer Compound Library Plus	L1023P-APE	2227 anti-cancer compounds
Kinase Inhibitor Library	L1024-APE	796 kinase inhibitors for high throughput screening (HTS) and high content screening (HCS)
GPCR Compound Library	L1025-APE	931 GPCR-related small molecules for GPCR screening
Neuronal Signaling Library	L1026-APE	556 neuronal signaling-related small molecules for neuroscience reasearch
Neuronal Signaling Compound Library Plus	L1026P-APE	948 neuronal signaling-related small molecules for neuroscience reasearch.
Anti-infection Compound Library	L1027-APE	367 anti-infection small molecules
Anti-infection Compound Library Plus	L1027P-APE	1004 anti-infection small molecules for anti-infection reasearch.
Tyrosine Kinase Inhibitor Library	L1028-APE	369 tyrosine kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).
Epigenetics Compound Library	L1029-APE	328 epigenetics-related small molecules for epigenetics reasearch.
Ion Channel Compound Library	L1030-APE	199 ion channel-related compounds for high throughput screening (HTS) and high content screening (HCS)
Ion Channel Compound Library Plus	L1030P-APE	350 ion channel-related compounds for high throughput screening (HTS) and high content screening (HCS)
Autophagy Compound Library	L1031-APE	486 autophagy-related compounds for autophagy research.
Autophagy Compound Library Plus	L1031P-APE	837 autophagy-related compounds for autophagy research
Metabolism-related Library	L1032-APE	493 metabolism-related compounds for metabolism research.
Metabolism-related Compound Library Plus	L1032P-APE	2065 metabolism-related compounds for metabolism research
DNA Damage/DNA Repair Library	L1033-APE	481 DNA Damage/DNA repair-related compounds for DNA damage/DNA repair research
PI3K/Akt/mTOR Compound Library	L1034-APE	178 PI3K/Akt/mTOR inhibitors for PI3K/Akt/mTOR signaling pathway research
Protease Inhibitor Library	L1035-APE	825 protease inhibitors for high throughput screening (HTS) and high content screening (HCS)
Apoptosis Compound Library	L1036-APE	643 apoptosis-related compounds for apoptosis research
Cell Cycle Library	L1037-APE	449 cell cycle-related compounds for cell cycle research
Histone Modification Library	L1038-APE	157 histone modification-related compounds for histone research
Natural Product Library	L1039-APE	550 natural products for high throughput screening (HTS) and high content screening (HCS)
Natural Product Library Plus	L1039P-APE	1655 natural products for high throughput screening (HTS) and high content screening (HCS)
Stem Cell Compound Library	L1040-APE	169 stem cell-related compounds
Stem Cell Compound Library Plus	L1040P-APE	280 stem cell-related compounds for stem cell research
JAK/STAT Compound Library	L1041-APE	109 JAK/STAT inhibitors for JAK/STAT signaling pathway research
Immunology/Inflammation Library	L1042-APE	295 small molecule compounds for immunology/inflammation research
Immunology/Inflammation Compound Library Plus	L1042P-APE	806 small molecule compounds for immunology/inflammation research
MAPK Inhibitor Library	L1043-APE	117 MAPK inhibitors for MAPK signaling pathway research
NF-κB Signaling Library	L1044-APE	73 NF-κB inhibitors
NF-κB Signaling Compound Library Plus	L1044P-APE	178 NF-κB inhibitors for NF-κB signaling pathway research
TGF-beta/Smad Compound Library	L1045-APE	88 TGF-beta/Smad inhibitors for TGF-beta/Smad signaling pathway research
Anti-diabetic Compound Library	L1046-APE	110 anti-diabetic small molecule compounds for diabetes research
Angiogenesis Library	L1047-APE	84 small molecule compounds for angiogenesis research
Inhibitor Library	L1048-APE	2525 inhibitors for high throughput screening (HTS) and high content screening (HCS)
Ubiquitination Compound Library	L1049-APE	A collection of 144 ubiquitination compounds supplied as lyophilized powder or pre-dissolved DMSO solutions
Anti-Virus Compound Library	L1050-APE	A collection of 509 Anti-Virus compounds supplied as lyophilized powder or pre-dissolved DMSO solutions
Human Endogenous Metabolite Compound Library	L1051-APE	A collection of 548 Human Endogenous Metabolite Compound supplied as lyophilized powder or pre-dissolved DMSO solutions
Medicine Food Homology Compound Library	L1053-APE	282 Medicine Food Homology compounds

Compound Library Advantages

Cost-effective and competitive price to save your findings.
Potent, selective and cell-permeable in inhibiting or activating target molecules.
Diverse in chemical structure and route of administration (oral/i.m/i.v injection etc.).
Detailed files describing potency, selectivity and applications etc.
Supported by published data from top peer-reviewed journals.
Guaranteed high quality with NMR and HPLC validation.

Bioactive Screening Libraries are ready-to-use chemical libraries used for drug discovery, lab drug screening, drug target identification, and other pharmaceutical-related applications. They are available for high-throughput screening (HTS) and high-content screening (HCS).

The libraries consist of over 2,500 small molecules with validated biological and pharmacological activities. The solubility, purity and stability of the compounds are also proved. Safety and effectiveness of the compounds has been demonstrated by literature, preclinical and clinical research, and many compounds are FDA-approved.
The collections of unique small molecules, which include inhibitors, antagonists and agonists. These compounds focused on hundreds of targets that are part of more than 20 signaling pathways or research areas, which include DNA Damage/DNA Repair, Cell Cycle/Checkpoint, JAK/STAT Signaling Pathway, MAPK Signaling Pathway, GPCR/G protein, Angiogenesis, Immunology/Inflammation, Endocrinology and Hormones, Cancer Biology, Metabolism, Stem Cell, etc.
We also provide customized bioactive screening libraries that allow you to choose the compounds, the sizes, the quantities, the format (powder or solution) and plate map you want in the library.

Screening Libraries

Compound Library Advantages

Bioactive Screening Libraries are ready-to-use chemical libraries used for drug discovery, lab drug screening, drug target identification, and other pharmaceutical-related applications. They are available for high-throughput screening (HTS) and high-content screening (HCS).

Compound Library Advantages

Bioactive Screening Libraries are ready-to-use chemical libraries used for drug discovery, lab drug screening, drug target identification, and other pharmaceutical-related applications. They are available for high-throughput screening (HTS) and high-content screening (HCS).

Tech Contact

General Contact

SUPPORT

PRODUCT

DELIVERY

Screening Libraries

Compound Library Advantages

Bioactive Screening Libraries are ready-to-use chemical libraries used for drug discovery, lab drug screening, drug target identification, and other pharmaceutical-related applications. They are available for high-throughput screening (HTS) and high-content screening (HCS).

Compound Library Advantages

Bioactive Screening Libraries are ready-to-use chemical libraries used for drug discovery, lab drug screening, drug target identification, and other pharmaceutical-related applications. They are available for high-throughput screening (HTS) and high-content screening (HCS).

Your first choice for scientific solutions

Tech Contact

General Contact

SUPPORT

PRODUCT

DELIVERY